Results 111 to 120 of about 127,650 (219)

Liquid biopsy in oncology practice: A global survey by the Young Committee of the International Society of Liquid Biopsy (ISLB). [PDF]

open access: yesJ Liq Biopsy
Nicolò E   +21 more
europepmc   +1 more source

A 1% glycopyrronium bromide cream for topical treatment of severe primary axillary hyperhidrosis in adolescents: safety, local tolerability, systemic exposure and efficacy from an open‐label phase II study

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives Primary axillary hyperhidrosis (PAHH) results from dysregulation of the autonomic nervous system and typically begins during puberty. Treatment options for adolescents remain limited. This open‐label phase II study evaluated the safety, local tolerability, systemic exposure, and efficacy of 1% GPB cream over 8 weeks in
Rolf‐Markus Szeimies   +8 more
wiley   +1 more source

[Mexico facing the measles epidemic: Figures that transcend borders]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Vallejos-Parás A   +6 more
europepmc   +1 more source

Trade Policy Uncertainty, Innovation Performance and Stock Price Crash Risk: Evidence From the Backbone of Corporate China

open access: yesEconomics &Politics, EarlyView.
ABSTRACT This study focuses on the exposure of leading Chinese firms to stock price crash risk amid the heightened policy uncertainty and geopolitical hostility of the US–China trade war. We find that Chinese multinationals with ex ante outward investments in the United States through cross‐border M&A or green field projects exhibit lower stock price ...
Yanguang (Alice) Liu   +2 more
wiley   +1 more source

Mediterranean Diet and Global Dietary Shifts, 1990-2018: Population-Level Analysis Using Global Dietary Database. [PDF]

open access: yesNutrients
Popescu-Spineni D   +8 more
europepmc   +1 more source

Prevalence and Patterns of Multiple Injuries Affecting a Single Permanent Tooth (Combination Injuries): A Systematic Review and Meta‐Analysis

open access: yesDental Traumatology, EarlyView.
ABSTRACT Background Combination injuries or multiple traumatic dental injuries (TDI) affecting a single permanent tooth are clinically significant but remain underrecognized. Although the global prevalence of TDI is well documented, the epidemiology of combination injuries has not been clearly established. This systematic review and meta‐analysis aimed
Nitesh Tewari   +6 more
wiley   +1 more source

Prognosis of Traumatized Permanent Teeth Affected by Multiple Injuries (Combination Injuries): A Systematic Review and Meta‐Analysis

open access: yesDental Traumatology, EarlyView.
ABSTRACT Background/Aims The prognosis of traumatic dental injuries (TDI) of permanent teeth depends on several factors related to the injury, patient characteristics, management, and follow‐up protocols. When such injuries affect both hard dental tissues and the periodontium (“combination injuries”), the risk of adverse healing complications increases.
Nitesh Tewari   +6 more
wiley   +1 more source

Patient and Healthcare Provider Satisfaction With Subcutaneous Versus Intravenous Administration of Daratumumab in Combination With Lenalidomide and Dexamethasone as First‐Line Treatment in Patients With Newly Diagnosed Non‐Transplant Eligible Multiple Myeloma: Final Results of the MYLENE Study

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Objectives The MYLENE non‐interventional study (NIS) aimed to close the gap in real‐world data on the experience and satisfaction with subcutaneous (sc) and intravenous (iv) daratumumab application in patients with newly diagnosed non‐transplant eligible multiple myeloma in Germany.
Eyck von der Heyde   +9 more
wiley   +1 more source

Early On‐Treatment Change in SALT as a Pragmatic Predictor of Ritlecitinib Response in Moderate‐To‐Severe Alopecia Areata: A Real‐World Cohort Study

open access: yesInternational Journal of Dermatology, EarlyView.
Ritlecitinib induced rapid clinical improvement in moderate‐to‐severe alopecia areata in real‐world practice. Early change in SALT at Week 12 strongly discriminated Week‐24 responders, supporting a pragmatic treat‐to‐target checkpoint, alongside improvements in clinician‐reported and patient‐reported outcomes and a favorable safety profile.
Giuseppe Gallo   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy